Table 1.
Distribution of patient and tumor characteristics among cases in this study
| N | % | |
|---|---|---|
| Total Cases | 205 | 100% |
| Center | ||
| Romania | 36 | 18% |
| Poland | 21 | 10% |
| Russia | 19 | 9% |
| Czech Republic* | 129 | 63% |
| Sex | ||
| Male | 122 | 60% |
| Female | 83 | 40% |
| Smoking Status | ||
| Never | 89 | 45% |
| Ever | 110 | 55% |
| BMI† | ||
| <25 | 54 | 26% |
| 25−35 | 147 | 72% |
| >35 | 4 | 2% |
| Self-Reported Hypertension | ||
| No | 108 | 53% |
| Yes | 97 | 47% |
| Tumor Stage | ||
| T | 42 | 20% |
| T2 | 92 | 45% |
| T3/T4 | 54 | 26% |
| missing | 17 | 8% |
| Metastasis | ||
| Mx | 37 | 18% |
| M0 | 148 | 72% |
| M1 | 9 | 4% |
| Missing | 11 | 5% |
| Fuhrman Nuclear Grade | ||
| I | 2 | 1% |
| II | 154 | 75% |
| III | 39 | 19% |
| IV | 3 | 1% |
| Missing | 7 | 3% |
*
Czech centers include Brno, Olomouc, Prague, Ceske Budejovice
†
Body Mass Index (BMI) at time of interview